Evidence map›Paper›PMID 39419353›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2025

Achieving accurate prostate auto-segmentation on CT in the absence of MR imaging.

Jingwei Duan, Riley C Tegtmeier, Carlos E Vargas, Nathan Y Yu, Brady S Laughlin, Jean-Claude M Rwigema, Justin D Anderson, Libing Zhu, Quan Chen, Yi Rong

Abstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jingwei DuanMayo Clinic Arizona, Phoenix, AZ, United States; The University of Alabama at Birmingham, Birmingham, AL, United States.
Riley C TegtmeierMayo Clinic Arizona, Phoenix, AZ, United States; The University of South Florida, Tampa, FL, United States.
Carlos E VargasMayo Clinic Arizona, Phoenix, AZ, United States.
Nathan Y YuMayo Clinic Arizona, Phoenix, AZ, United States.
Brady S LaughlinMayo Clinic Arizona, Phoenix, AZ, United States.
Jean-Claude M RwigemaMayo Clinic Arizona, Phoenix, AZ, United States.
Justin D AndersonMayo Clinic Arizona, Phoenix, AZ, United States.
Libing ZhuMayo Clinic Arizona, Phoenix, AZ, United States.
Quan ChenMayo Clinic Arizona, Phoenix, AZ, United States. Electronic address: chen.quan@mayo.edu.
Yi RongMayo Clinic Arizona, Phoenix, AZ, United States. Electronic address: rong.yi@mayo.edu.

Funding

Automatic Organ Segmentation Tool for Radiation Treatment Planning of CancersR44CA254844 · NCI · CARINA MEDICAL, LLC · PI FENG, XUE · 2020 to 2022
$2.0M
NCI NIH HHS R44 CA254844
6 · The paper itself

Abstract

backgroundMagnetic resonance imaging (MRI) is considered the gold standard for prostate segmentation. Computed tomography (CT)-based segmentation is prone to observer bias, potentially overestimating the prostate volume by ∼ 30 % compared to MRI. However, MRI accessibility is challenging for patients with contraindications or in rural areas globally with limited clinical resources. PURPOSE: This study investigates the possibility of achieving MRI-level prostate auto-segmentation accuracy using CT-only input via a deep learning (DL) model trained with CT-MRI registered segmentation. METHODS AND MATERIALS: A cohort of 111 definitive prostate radiotherapy patients with both CT and MRI images was retrospectively grouped into training (n = 37) and validation (n = 20) (where reference contours were derived from CT-MRI registration), and testing (n = 54) sets. Two commercial DL models were benchmarked against the reference contours in the training and validation sets. A custom DL model was incrementally retrained using the training dataset, quantitatively evaluated on the validation dataset, and qualitatively assessed by two different physician groups on the validation and testing datasets. A contour quality assurance (QA) model, established from the proposed model on the validation dataset, was applied to the test group to identify potential errors, confirmed by human visual inspection.

resultsTwo commercial models exhibited large deviations in the prostate apex with CT-only input (median: 0.77/0.78 for Dice similarity coefficient (DSC), and 0.80 cm/0.83 cm for 95 % directed Hausdorff Distance (HD95), respectively). The proposed model demonstrated superior geometric similarity compared to commercial models, particularly in the apex region, with improvements of 0.05/0.17 cm and 0.06/0.25 cm in median DSC/HD95, respectively. Physician evaluation on MRI-CT registration data rated 69 %-78 % of the proposed model's contours as clinically acceptable without modifications. Additionally, 73 % of cases flagged by the contour quality assurance (QA) model were confirmed via visual inspection.

conclusionsThe proposed incremental learning strategy based on CT-MRI registration information enhances prostate segmentation accuracy when MRI availability is limited clinically.

Indexed as

Deep LearningMagnetic Resonance ImagingProstatic NeoplasmsTomography, X-Ray ComputedHumansMaleProstateRadiotherapy Planning, Computer-AssistedRetrospective Studies

Identifiers

PMID39419353
PMCPMC11663129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.